Estrogen Receptor Positive Breast Cancer Active Not Recruiting Phase 2 Trials for Palbociclib (DB09073)

Also known as: Oestrogen receptor positive breast cancer

IndicationStatusPhase
DBCOND0049177 (Estrogen Receptor Positive Breast Cancer)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03633331Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast CancerTreatment